Provention bio to report third quarter 2020 financial results and host conference call on thursday, november 5, 2020

Red bank, n.j., oct. 29, 2020 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing autoimmune disease, today announced that it will report its third quarter 2020 financial results on thursday, november 5, 2020. in...

PRVB Ratings Summary

PRVB Quant Ranking